Literature DB >> 28449527

Invited Editorial on "the timing of surgery after neoadjuvant chemoradiation in locally advanced non-small cell lung cancer".

Deniz Yalman1.   

Abstract

Entities:  

Year:  2017        PMID： 28449527      PMCID： PMC5394026          DOI： 10.21037/jtd.2017.02.98

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

1.  Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.

Authors:  Miklos Pless; Roger Stupp; Hans-Beat Ris; Rolf A Stahel; Walter Weder; Sandra Thierstein; Marie-Aline Gerard; Alexandros Xyrafas; Martin Früh; Richard Cathomas; Alfred Zippelius; Arnaud Roth; Milorad Bijelovic; Adrian Ochsenbein; Urs R Meier; Christoph Mamot; Daniel Rauch; Oliver Gautschi; Daniel C Betticher; René-Olivier Mirimanoff; Solange Peters
Journal:  Lancet       Date:  2015-08-11       Impact factor: 79.321

Review 2.  Neoadjuvant chemoradiotherapy followed by surgery for stage IIIa and IIIb non-small-cell lung cancer (NSCLC): is it still justified?

Authors:  René-Olivier Mirimanoff
Journal:  Chin Clin Oncol       Date:  2015-12

3.  Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer.

Authors:  Michael Thomas; Christian Rübe; Petra Hoffknecht; Hans N Macha; Lutz Freitag; Albert Linder; Norman Willich; Michael Hamm; Gerhard W Sybrecht; Dieter Ukena; Karl-Matthias Deppermann; Cornelia Dröge; Dorothea Riesenbeck; Achim Heinecke; Cristina Sauerland; Klaus Junker; Wolfgang E Berdel; Michael Semik
Journal:  Lancet Oncol       Date:  2008-06-24       Impact factor: 41.316

4.  Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Sarah J Gao; Christopher D Corso; Elyn H Wang; Justin D Blasberg; Frank C Detterbeck; Daniel J Boffa; Roy H Decker; Anthony W Kim
Journal:  J Thorac Oncol       Date:  2016-10-05       Impact factor: 15.609

5.  Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.

Authors:  Hong Kwan Kim; Jong Ho Cho; Yong Soo Choi; Jae Ill Zo; Young Mog Shim; Keunchil Park; Myung-Ju Ahn; Yong Chan Ahn; Kwhanmien Kim; Jhingook Kim
Journal:  Lung Cancer       Date:  2016-03-29       Impact factor: 5.705

6.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

Review 7.  Anatomical lung resection after neoadjuvant chemoradiotherapy.

Authors:  Whitney M Burrows
Journal:  Semin Thorac Cardiovasc Surg       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.